Autolus Therapeutics Ltd reported $-78.59M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AstraZeneca USD 3.24B 117M Sep/2025
Autolus Therapeutics Ltd USD -78.59M 31.07M Sep/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Novartis USD 4.64B 445M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025